You heard it here first !!!

Quote

Anonymous

Guest
Merck plans on dropping 50+ percent of the sales force, all HSCs, MGAMs and NAEs.

These personnel will be replaced with Inventiv reps and an unknown number of MADs (Medical Account Directors). The inventiv reps will be responsible for routine promotion, the MADS will call on State, Federal, GPOs and large hospital accounts.

Schecter and McMahon have convinced the board of directors that US physicians no longer have the autonomy to influence scripts. It is quite convenient that this shift in focus gives them something to distract the board with so that they can continue to milk Merck for another 4-5 years (and then they will go the way of all failed mrk VPs...golden chute) (Think MGlynn, Thomas, Vignau, Kim)

This mode of thinking is a tad early for the US market. Shecky and Bobby !!! this is not the UK !!! We know you want to shift the blame from yourself to some other obtuse point of focus, but c'mon you had best sanction some more market research before you ___ things up even further !!!
 




Then why do people here have to be so darn snarky and not supportive of those going through layoffs or undoubtedly will in the future. No offenses, but if the pharm industry has fallen to such lows, I don't have much sympathy for those who are kept on.

We're through with pharm. plenty of Ph.D. stats people needed elsewhere.
 




Anonymous said:
Then why do people here have to be so darn snarky and not supportive of those going through layoffs or undoubtedly will in the future. No offenses, but if the pharm industry has fallen to such lows, I don't have much sympathy for those who are kept on.

We're through with pharm. plenty of Ph.D. stats people needed elsewhere.
Click to expand...

Ph.D is becoming meaningless in America. It's a shame but true. They are more concerned about crappy MBA's than what is really needed to drive a company. The only real money is in bankers and pencil pushers. I have never seen any MBA have vision.
 




Anonymous said:
Ph.D is becoming meaningless in America. It's a shame but true. They are more concerned about crappy MBA's than what is really needed to drive a company. The only real money is in bankers and pencil pushers. I have never seen any MBA have vision.
Click to expand...

In defense of the MBAs....they have terrific skills if they're using what their degree courses taught...Yes, the PhD is basically useless unless you have some obscure scientific specialty....Know a few PhDs making a whopper 40K salary range and education cost over 200K. Its not a career booster unless you have a high demand specialization...
 




Anonymous said:
Then why do people here have to be so darn snarky and not supportive of those going through layoffs or undoubtedly will in the future. No offenses, but if the pharm industry has fallen to such lows, I don't have much sympathy for those who are kept on.

We're through with pharm. plenty of Ph.D. stats people needed elsewhere.
Click to expand...

Stop shirking. Get to work.
 




Anonymous said:
Merck plans on dropping 50+ percent of the sales force, all HSCs, MGAMs and NAEs.

These personnel will be replaced with Inventiv reps and an unknown number of MADs (Medical Account Directors). The inventiv reps will be responsible for routine promotion, the MADS will call on State, Federal, GPOs and large hospital accounts.

Schecter and McMahon have convinced the board of directors that US physicians no longer have the autonomy to influence scripts. It is quite convenient that this shift in focus gives them something to distract the board with so that they can continue to milk Merck for another 4-5 years (and then they will go the way of all failed mrk VPs...golden chute) (Think MGlynn, Thomas, Vignau, Kim)

This mode of thinking is a tad early for the US market. Shecky and Bobby !!! this is not the UK !!! We know you want to shift the blame from yourself to some other obtuse point of focus, but c'mon you had best sanction some more market research before you ___ things up even further !!!
Click to expand...


I don't doubt that sooner of later we are in for a real shocker with more people severed from the company than anticipated. Where are you getting this info? Are you an insider at corporate? PC Rep here trying to make some life altering decisions for my family and me. Husband is in pharma sales and facing lay-off too.
 




Anonymous said:
I don't doubt that sooner of later we are in for a real shocker with more people severed from the company than anticipated. Where are you getting this info? Are you an insider at corporate? PC Rep here trying to make some life altering decisions for my family and me. Husband is in pharma sales and facing lay-off too.
Click to expand...

Well, I hope you are both young enough to make those life altering decisions by getting far away from pharma sales. You need look no further than what you see in your own territory with regard to sales and decision making. The pharma sales charade is not going to be paying what it used to. Not a long term career for anyone anymore.
 








Anonymous said:
Pharma reps are well beyond their usefulness. This is a good business move, but it will hurt thousands of additional pharma reps and their families.
Click to expand...

Buying a pipeline while we move all of r&d and production to china is a better one. How useful is r&d? 7 years with nothing to show for it. You can never disagree with that.

That is the direction we are going.
 




Anonymous said:
Buying a pipeline while we move all of r&d and production to china is a better one. How useful is r&d? 7 years with nothing to show for it. You can never disagree with that.

That is the direction we are going.
Click to expand...

If we move one pill it's more than what r&d has done in years. The cuts are still coming next week.

Enjoy
 








Top Bottom
Back
Quote